A distinct strategy was adopted by Zhang et al. employing multicolored fluorescent flow cytometry to characterize both myeloma and immune cells and to further classify CD3+/CD8+ T-cells into different subsets [15]. This evidence concerns the gene CD8A and plasma cell myeloma.